KB-407

N/A

Report date: 2024/09/19 13:54:09

Base Information

Drug NameKB-407

Drug Alias NameKB-407

ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Herpes simplex virus vector

Mechanisms of ActionCFTR gene transference

TargetsCystic fibrosis transmembrane conductance regulator

Therapy Area/IndicationsCystic Fibrosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesAustralia

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesKrystal Biotech Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsCystic Fibrosis

Inactive IndicationsN/A

ATC CodeN/A